Stay updated with breaking news from Peyton greenside. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AI-Created Antibodies Drive Innovation at BigHat Biosciences genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Some of the most promising and cutting-edge advancements in climate tech and health tech will be on display at Disrupt 2022, set for October 18–20 in San Francisco. ....
Disrupt is turning 12 years old. If it were a human, it would be addicted to technology (which it is) and starting to get an attitude (again, yes). But after a couple of years coming to you virtually, the world’s most impactful tech startup conference is coming back to real life. The Moscone Center will […] ....
Press release content from Business Wire. The AP news staff was not involved in its creation. BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments February 10, 2021 GMT BigHat co-founders Mark DePristo and Peyton Greenside (Photo: Business Wire) SAN CARLOS, Calif. (BUSINESS WIRE) Feb 10, 2021 BigHat Biosciences, a novel protein therapeutics company and developer of an AI-guided antibody design platform, today announced it has raised $19 million in an oversubscribed Series A funding round, led by Andreessen Horowitz, with participation from prior investors 8VC, AME Cloud Ventures and Innovation Endeavors. As part of the investment, Andreessen Horowitz General Partner, Vineeta Agarwala, MD, PhD joins BigHat’s Board of Directors. ....